{
    "Overall_score": {
        "Correlation": 8,
        "Sentiment": 6,
        "Importance": 7,
        "Impact": 7,
        "Duration": 5,
        "Virality": 4,
        "Source_Score": 7,
        "Specificity": 8,
        "Sector_Spread": 6,
        "Tech_Mentions": 3
    },
    "Each_item": [
        {
            "News_content": "Pfizer Says FDA Accepts For Review SNDA For Oral XELJANZ",
            "Correlation": 9,
            "Sentiment": 7,
            "Importance": 6,
            "Impact": 5,
            "Duration": 4,
            "Virality": 3,
            "Source_Score": 8,
            "Specificity": 9,
            "Sector_Spread": 4,
            "Tech_Mentions": 2
        },
        {
            "News_content": "Akorn stock is breaking out, in buy range. Chart analysis here",
            "Correlation": 8,
            "Sentiment": 6,
            "Importance": 4,
            "Impact": 6,
            "Duration": 3,
            "Virality": 5,
            "Source_Score": 6,
            "Specificity": 7,
            "Sector_Spread": 3,
            "Tech_Mentions": 8
        },
        {
            "News_content": "New intraday upward trend on Pfizer, Inc. - up 0.92% in 43 minutes",
            "Correlation": 8,
            "Sentiment": 5,
            "Importance": 3,
            "Impact": 4,
            "Duration": 2,
            "Virality": 4,
            "Source_Score": 7,
            "Specificity": 8,
            "Sector_Spread": 3,
            "Tech_Mentions": 7
        },
        {
            "News_content": "Pfizer finally strikes a huge deal in this $17B play for injectables/biosimilars giant Hospira",
            "Correlation": 10,
            "Sentiment": 8,
            "Importance": 9,
            "Impact": 8,
            "Duration": 6,
            "Virality": 6,
            "Source_Score": 8,
            "Specificity": 10,
            "Sector_Spread": 7,
            "Tech_Mentions": 1
        },
        {
            "News_content": "Pfizer Invites Investors, Analysts And Media To Join Conference Calls Discussing Pfizerâ€™s Proposed",
            "Correlation": 9,
            "Sentiment": 6,
            "Importance": 7,
            "Impact": 6,
            "Duration": 5,
            "Virality": 4,
            "Source_Score": 8,
            "Specificity": 8,
            "Sector_Spread": 6,
            "Tech_Mentions": 1
        },
        {
            "News_content": "The Hospira deal: What's in it for Pfizer",
            "Correlation": 9,
            "Sentiment": 6,
            "Importance": 7,
            "Impact": 6,
            "Duration": 5,
            "Virality": 4,
            "Source_Score": 7,
            "Specificity": 8,
            "Sector_Spread": 6,
            "Tech_Mentions": 1
        },
        {
            "News_content": "Pfizer to buy Hospira for $15 billion to boost copycat drug business",
            "Correlation": 10,
            "Sentiment": 7,
            "Importance": 8,
            "Impact": 7,
            "Duration": 6,
            "Virality": 5,
            "Source_Score": 8,
            "Specificity": 9,
            "Sector_Spread": 7,
            "Tech_Mentions": 1
        },
        {
            "News_content": "The Problem With Pfizer's $17 Billion Buy",
            "Correlation": 9,
            "Sentiment": 4,
            "Importance": 7,
            "Impact": 5,
            "Duration": 5,
            "Virality": 4,
            "Source_Score": 7,
            "Specificity": 8,
            "Sector_Spread": 6,
            "Tech_Mentions": 1
        }
    ]
}